Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.737,37
-0,77%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Locust Walk Acquisition Corporation (LWAC) Locust Walk Acquisition Corporation (LWAC) Notizie

LWAC

Locust Walk Acquisition (LWAC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LWAC
DataOraFonteTitoloSimboloCompagnia
27/06/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LWACLocust Walk Acquisition Corporation
23/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LWACLocust Walk Acquisition Corporation
08/06/202312:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LWACLocust Walk Acquisition Corporation
08/06/202312:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:LWACLocust Walk Acquisition Corporation
16/05/202314:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LWACLocust Walk Acquisition Corporation
12/05/202322:24Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:LWACLocust Walk Acquisition Corporation
12/05/202322:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LWACLocust Walk Acquisition Corporation
12/05/202322:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LWACLocust Walk Acquisition Corporation
09/05/202322:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LWACLocust Walk Acquisition Corporation
08/03/202322:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:LWACLocust Walk Acquisition Corporation
07/03/202323:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LWACLocust Walk Acquisition Corporation
14/02/202312:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LWACLocust Walk Acquisition Corporation
28/09/202222:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LWACLocust Walk Acquisition Corporation
11/08/202222:56Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LWACLocust Walk Acquisition Corporation
18/03/202211:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LWACLocust Walk Acquisition Corporation
25/01/202222:32Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:LWACLocust Walk Acquisition Corporation
17/12/202122:32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:LWACLocust Walk Acquisition Corporation
01/10/202123:14Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:LWACLocust Walk Acquisition Corporation
03/09/202122:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LWACLocust Walk Acquisition Corporation
26/08/202101:18GlobeNewswire Inc.eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer TherapiesNASDAQ:LWACLocust Walk Acquisition Corporation
24/08/202122:47GlobeNewswire Inc.Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer TherapiesNASDAQ:LWACLocust Walk Acquisition Corporation
23/08/202114:58Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:LWACLocust Walk Acquisition Corporation
09/08/202123:28Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:LWACLocust Walk Acquisition Corporation
22/07/202114:00GlobeNewswire Inc.eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral AgentNASDAQ:LWACLocust Walk Acquisition Corporation
16/07/202114:00GlobeNewswire Inc.eFFECTOR Therapeutics Announces Publication of Tomivosertib Preclinical Data in Cell ReportsNASDAQ:LWACLocust Walk Acquisition Corporation
03/06/202122:15GlobeNewswire Inc.Locust Walk Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report ...NASDAQ:LWACLocust Walk Acquisition Corporation
27/05/202114:00GlobeNewswire Inc.eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation ...NASDAQ:LWACLocust Walk Acquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LWAC

La tua Cronologia

NASDAQ
VTC
Vanguard Total Corporate
USOTC
ZAILF
Zai Lab (PK)
TSX
POW.PR.D
Power Corp of Canada
COIN
GAMUSD
USOTC
ASEJF
APT Satellite (PK)
EU
XS1828037827
TenneT Holding 2% 05jun2...
COIN
KLNEUR
COIN
FIREETH
Fire Protocol
NYSE
OILT
Texas Capital Fu
COIN
TRAAAUST
TRIA
LATK
NERVEUSDT
NERVEFLUX
COIN
BTCSTUSD
StandardBTCHashrateToken
COIN
THXGBP
ThoreNext
XE
H9Y
Hanseyachts On
NYSE
REXR-C
Rexford Individual Realty
TG
OTE
Hellenic Telecommunicati...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network